Navigation Links
Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
Date:8/13/2012

LOS ANGELES and BOSTON, Aug. 13, 2012 /PRNewswire/ -- ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that Abbie Celniker, Ph.D. has joined the company as a Director and Chair of the Board.

"In ImaginAb's search for Board leadership, we set out to attract an industry visionary with perspective from big biopharma as well as entrepreneurial experience and we have found all of these qualities in Dr. Celniker." said Christian Behrenbruch, Ph.D., Chief Executive Officer of ImaginAb. "We are delighted to welcome Dr. Celniker to our team and look forward to her contributions as we develop our groundbreaking in vivo molecular imaging agents."

"Companion diagnostic strategies are increasingly critical to new therapeutic management strategies in the oncology and immunology space," commented Dr. Celniker. "ImaginAb's platform for re-engineering therapeutic antibody drugs into imaging agents is unique in the industry and bears great potential. ImaginAb is beginning to realize the promise of this technology by advancing its internal clinical pipeline in cancer and autoimmune diseases, as well as multiple collaborations with biopharma."

Abbie Celniker, Ph.D., is currently President and CEO of Eleven Biotherapeutics (Boston, MA) and brings more than 20 years of proven expertise in building protein discovery and development programs and biologics-focused businesses. Prior to Eleven Biotherapeutics, she led Taligen, which was acquired by Alexion Pharmaceuticals in 2011. Dr. Celniker was formerly the global head of biologics at Novartis, where she forged strategic alliances and led internal discovery and development to build the pipeline. Earlier in her career, Dr. Celniker spent more than six years at Millennium Pharmaceuticals as senior vice president, R&D strategy and operations and head of biotherapeutics and pharmaceutical sciences. She also held deve
'/>"/>

SOURCE ImaginAb, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
2. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
3. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
4. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
5. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
6. TMG Health To Present Kip Piper at Thought Leadership Dinner
7. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
8. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
9. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... ALEXANDRIA, Va. , July 30, 2014 /PRNewswire-USNewswire/ ... of Managed Care Pharmacy (AMCP) last evening expressed ... developed by the Joint Commission of Pharmacy Practitioners ... other member organizations over a two-year period to ... process for pharmacists.  "Pharmacists are ...
(Date:7/30/2014)... 30, 2014 PuraMed BioScience ® , ... over-the-counter (OTC) medicinal and healthcare products, announced today ... name along with the name,s red and yellow ... trademarked name MigraPure ®  going forward. The ... homeopathic, natural migraine pain reliever will be reintroduced ...
(Date:7/30/2014)... -- Research and Markets has announced the addition of ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... a lower CAGR in developed countries; however, it is expected to ... , India , and Brazil ... of the hematology analyzers and reagents market is driven by factors ...
Breaking Medicine Technology:AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... 13, 3010 Amgen (Nasdaq: AMGN ) ... evaluating XGEVA™ (denosumab) versus placebo in 1,432 men with ... study, demonstrated that XGEVA significantly improved median bone metastasis-free ... p=0.03) compared to placebo (primary endpoint), and significantly improved ...
... Fla., Dec. 13, 2010 The creators of the innovative Pill ... toys and a much needed medication management system to pediatric ... at Broward General, in Fort Lauderdale, Florida. ... will be onsite Wednesday, December 15, from 1-3 pm distributing ...
Cached Medicine Technology:XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 2XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 3XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 4XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 5XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 6XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 7Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Children's Hospital of Broward General 2
(Date:7/30/2014)... York, NY (PRWEB) July 30, 2014 Frozen ... Women are more likely to develop this nasty condition which ... and 60, and can last up to two and half ... known as frozen shoulder, and with good reason: it can ... your shirt — that is, if you aren't in too ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- For patients ... is enough to trigger airway inflammation for at least ... just what you smell, but also what you think ... Monell Chemical Senses Center in Philadelphia, said in a ... about scents and fragrances. When we expect that an ...
(Date:7/30/2014)... vast majority of kids with autism have abnormal sensory ... children who have trouble processing sensory stimuli, researchers report. ... overly sensitive to sound, sight and touch. They can ... of concentration. Complicating matters, some kids with SPD ... tolerating loud noises, like a vacuum. Others can,t hold ...
(Date:7/30/2014)... Young adults who were breastfed for three months ... risk of chronic inflammation associated with cardiovascular and ... School at Washington University in St. Louis. , ... have implications for children,s health decades later," said ... Brown School and a co-author of the study ...
(Date:7/30/2014)... India (PRWEB) July 30, 2014 On ... Campaign, and the Indian Institute of Public Health, Gandhinagar ... Microfinance in India, Volume II: The Way Forward .” ... Asia Conference on Policies and Practices to Improve Nutrition ... the "Indian Father of the Green Revolution" and chair ...
Breaking Medicine News(10 mins):Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 3Health News:Birthweight and breastfeeding have implications for children's health decades later 2Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 2Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 3Health News:New Report on Integrated Health and Microfinance in India Shows the Way Forward 4
... , - Misys BankFusion Universal Banking at the ... MSY.L), the global application software and services,company, today announces ... Banking., Government owned until 1996, CRDB Bank is ... 10 new branches a year, launch a fully,automated and ...
... with proven results. Women have seen increases of ½ to 2 ... comes from a blend of 13 different herbs, all of which ... effective for natural breast enhancement. , ... Port St. ...
... Intelligent Document Solutions to Speed Up Vision Plan ... Claim Processes, Improves ... August 18 /PRNewswire-FirstCall/,-- Autonomy Corporation plc (LSE: AU. ... the enterprise, today announced that General,Vision Services (GVS) ...
... of interpersonal conflict have a three-fold greater risk of ... to a new study by University of California, Davis, ... have never had a diagnosis of depression. , ... (EDT) poster session, "Improving Our Practice -- ,Focus on ...
... urged psychologists today to take a leading role ... upon the profession to provide "appropriate, nondiscriminatory treatment ... more research into all aspects of gender identity ... Annual Convention when the association,s governing Council of ...
... high performance mass spectrometry products and applications for proteomics at the ... ... The Netherlands (Business Wire EON) August 17, 2008 -- maXis™ ... mass spectrometer platform, and truly represents a revolution in tandem mass ...
Cached Medicine News:Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 2Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 3Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 2Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4Health News:Suicide in Asian Americans 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 2Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 4
Inquire...
... with low electroendosmosis (EEO) ... DNA/RNA applications. If separated ... be used as substrates ... and restriction endonucleases, a ...
... NuSieve 3:1 Agarose is a molecular biology grade, ... for fine resolution of small DNA, RNA, and ... enhance the speed of gel processing and blotting. ... resolution of DNA fragments up to 1,000 bp, ...
... With a very high gel ... exclusion limit, Certified megabase agarose is ... FIGE applications. The gels remain easy ... as 0.3% and allow shorter run ...
Medicine Products: